Multiple Sclerosis and Seizures: a Retrospective Observational Study in a Multiple Sclerosis Autoimmunity Center of Excellence

The prevalence of epilepsy in patients with multiple sclerosis (MS) is three to six times the prevalence in the general adult population[1]. While 1-1.5% of the general population have seizures, approximately 2-5% of people with MS have seizures. The cumulative incidence of epilepsy is also higher rising with increasing disease duration [2]. Mechanisms resulting in increased seizure risk are not fully understood. Seizures occur at different MS stages, perhaps suggesting different pathophysiology and management approach[3,4].

Seguir leyendo →
0

Neurological Autoantibody Prevalence in Chronic Epilepsy: Clinical and Neuropathologic Findings

Seizure is a common symptom of autoimmune encephalitis [1], and in the latest International League Against Epilepsy (ILAE) classifications guideline of epilepsy, immune etiology was listed as one of six etiologies [2]. In recent decades, the term “autoimmune epilepsy” has been increasingly used in publications; however, some are controversial, as “autoimmune epilepsy” has been applied to seizures in the acute phase of immune-mediated encephalitis [3–5]. Epilepsy is a chronic brain disorder that is different from seizures; therefore, some experts emphasize ...

Seguir leyendo →
0

Optimal duration for recording EEG in children and adolescents- a prospective interventional study

An EEG (electroencephalogram) is crucial for diagnosing, monitoring, and syndromic classification of epilepsy [1]. In individuals experiencing seizures, an epileptiform EEG displaying generalized spike and wave discharges predicts a five-year recurrence risk of 58%, compared to 26% for those with a non-epileptiform EEG [2]. A single 30-minute outpatient EEG reveals interictal epileptiform discharges (IEDs) in 29-56% of epilepsy patients, increasing to 82% with repeated EEGs [3–5]. The cumulative yield after a second and third EEG following a first unprovoked seizure ...

Seguir leyendo →
0

Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy.

Epilepsy surgery is an effective treatment option for drug-resistant focal epilepsy (FE), provided that the patient is a suitable candidate for the procedure [1]. Typically, individuals undergo evaluation in an Epilepsy Monitoring Unit (EMU) to determine their eligibility for surgery [2]. Long term Video-EEG monitoring (LTM) is an essential component of this presurgical evaluation [3]. The goal is to capture several seizures to verify that they are stereotypical and that the epilepsy is unifocal [4].

Seguir leyendo →
0

Neuroimaging correlation with EEG in status epilepticus

Status epilepticus (SE) is a life-threating condition with overall mortality approaching 20%, in which generalized convulsive status epilepticus (CSE) represents about 45–74% of all cases. [1,2] SE was originally defined as recurrent seizures without recovery between seizure activities or a seizure with 5 minutes or more of continuous clinical seizure with or without electrographic seizure activity; although, it was not practical in real clinical settings. In 2015, the International League Against Epilepsy proposed a new definition of SE: 5 minutes ...

Seguir leyendo →
0

Early Prediction of Drug-Resistant Epilepsy using Clinical and EEG Features Based on Convolutional Neural Network

Epilepsy is a spontaneous and serious neurological disorder that presents with recurrent seizures and affects around 50 million people globally [1]. Unfortunately, despite recent advances in the development of antiseizure medications (ASMs), drug-resistant epilepsy (DRE) still affects 20% to 30% of patients with epilepsy (PWE) [1–3]. Patients with DRE bear significant economic, social, physical, and psychological burdens, but it takes a long time to identify DRE after repetitive ASMs trial, identifying patients at high risk of developing DRE early may ...

Seguir leyendo →
0
Página 7 de 181 «...56789...»